Literature DB >> 2076865

Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis.

K Blessing1, K M McLaren, A McLean, P Davidson.   

Abstract

It is known that not all thin malignant melanomas have an excellent prognosis and that the specific features identifying the patients at risk of metastasis have not been fully elucidated. We have looked at thin malignant melanomas (less than 1.5 mm) in the East of Scotland that had proven metastasis and death, and compared the clinical and histological features with a similar group (less than 1.5 mm) that have had no further recurrence after a minimum of 6-year follow-up. We identified 26 patients with thin melanomas who had developed histologically proven metastasis and/or died following adequate surgical treatment of their primary lesion. When compared with the control group, factors found to be significantly different between the two groups and present in the group that did badly were (a) histological regression, (b) lesion size, (c) Clark level IV and (d) depth of the uninvolved dermis.

Entities:  

Mesh:

Year:  1990        PMID: 2076865     DOI: 10.1111/j.1365-2559.1990.tb00757.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  The significance of inflammation and regression in melanoma.

Authors:  M G Cook
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 2.  Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.

Authors:  R L Barnhill; M A Levy
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

3.  Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.

Authors:  Susannah E McClain; Amber L Shada; Megan Barry; James W Patterson; Craig L Slingluff
Journal:  Melanoma Res       Date:  2012-08       Impact factor: 3.599

Review 4.  Tissue prognostic biomarkers in primary cutaneous melanoma.

Authors:  Mario Mandalà; Daniela Massi
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

5.  Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

Authors:  Soheil S Dadras; Thomas Paul; Jennifer Bertoncini; Lawrence F Brown; Alona Muzikansky; David G Jackson; Ulf Ellwanger; Claus Garbe; Martin C Mihm; Michael Detmar
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

6.  Breslow thickness of cutaneous malignant melanoma in paraffin wax and frozen sections.

Authors:  N Kirkham; K Blessing; B Gibson; M L Price
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

7.  Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).

Authors:  Melanie A Warycha; Jan Zakrzewski; Quanhong Ni; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Iman Osman
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

8.  Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas.

Authors:  C H Graham; J Rivers; R S Kerbel; K S Stankiewicz; W L White
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

9.  Is There a Relationship Between TILs and Regression in Melanoma?

Authors:  Steven Morrison; Gang Han; Faith Elenwa; John T Vetto; Graham Fowler; Stanley P Leong; Mohammed Kashani-Sabet; Barbara Pockaj; Heidi E Kosiorek; Jonathan S Zager; Jane L Messina; Nicola Mozzillo; Schlomo Schneebaum; Dale Han
Journal:  Ann Surg Oncol       Date:  2022-01-21       Impact factor: 5.344

10.  Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?

Authors:  Daniela Göppner; Martin Leverkus
Journal:  J Skin Cancer       Date:  2011-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.